Safety of very tight blood glucose control in type 2 diabetes
- PMID: 18309965
- PMCID: PMC2258341
- DOI: 10.1136/bmj.39499.514410.80
Safety of very tight blood glucose control in type 2 diabetes
Abstract
Aim for glycated haemoglobin lower than 6.5%, but without using highly intensive treatment
Conflict of interest statement
Competing interests: Institutions associated with PH receive funding from all the major manufacturers of oral agents and insulin regarding his educational, consultative, and research activities.
Comment in
-
Very tight glucose control: May be high risk, low benefit.BMJ. 2008 Mar 29;336(7646):683. doi: 10.1136/bmj.39520.531319.3A. BMJ. 2008. PMID: 18369208 Free PMC article. No abstract available.
References
-
- National Heart, Lung, and Blood Institute. For safety, NHLBI changes intensive blood sugar treatment strategy in clinical trial of diabetes and cardiovascular disease. 2008. http://public.nhlbi.nih.gov/newsroom/home/GetPressRelease.aspx?id=2551
-
- Clinical Guidelines Task Force. Global guideline for the management of type 2 diabetes Brussels, International Diabetes Federation, 2005. www.idf.org/home/index.cfm?node=1457
-
- Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones. Diabetologia 2007;51:8-11. - PubMed
-
- UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53. - PubMed
-
- UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical